Connection

David Taber to Retrospective Studies

Back to Details
This is a "connection" page, showing publications David Taber has written about Retrospective Studies.
David Taber
Connection Strength
3.013
Retrospective Studies
  1. Clinical Outcomes of Older Kidney Transplant Recipients. Am J Med Sci. 2021 08; 362(2):130-134.
    View in: PubMed
    Score: 0.078
  2. Virtual Crossmatching in Kidney Transplantation: The Wait Is Over. J Am Coll Surg. 2020 04; 230(4):373-379.
    View in: PubMed
    Score: 0.073
  3. Long-term Assessment of NSAID Prescriptions and Potential Nephrotoxicity Risk in Adult Kidney Transplant Recipients. Transplantation. 2019 12; 103(12):2675-2681.
    View in: PubMed
    Score: 0.072
  4. Development and future deployment of a 5 years allograft survival model for kidney transplantation. Nephrology (Carlton). 2019 Aug; 24(8):855-862.
    View in: PubMed
    Score: 0.069
  5. The Impact of Dual Health Care System Use for Obtaining Prescription Medications on Nonadherence in Veterans With Type 2 Diabetes. Ann Pharmacother. 2019 07; 53(7):675-682.
    View in: PubMed
    Score: 0.068
  6. Change in Mycophenolate and Tacrolimus Exposure by Transplant Vintage and Race. Exp Clin Transplant. 2019 12; 17(6):707-713.
    View in: PubMed
    Score: 0.067
  7. The impact of time-varying clinical surrogates on disparities in African-American kidney transplant recipients - a retrospective longitudinal cohort study. Transpl Int. 2019 01; 32(1):84-94.
    View in: PubMed
    Score: 0.066
  8. Characterization of Potentially Unsafe Ambulatory Antibiotic Use and Associated Outcomes in an Adult Kidney Transplant Population. Ann Pharmacother. 2018 10; 52(10):974-982.
    View in: PubMed
    Score: 0.065
  9. Renal Function Variability: An Independent Risk Factor for Graft Loss and Death following Kidney Transplantation. Am J Nephrol. 2018; 47(3):191-199.
    View in: PubMed
    Score: 0.064
  10. Transplant Center Variability in Disparities for African-American Kidney Transplant Recipients. Ann Transplant. 2018 Feb 16; 23:119-128.
    View in: PubMed
    Score: 0.064
  11. Incidence and impact of adverse drug events contributing to hospital readmissions in kidney transplant recipients. Surgery. 2018 02; 163(2):430-435.
    View in: PubMed
    Score: 0.063
  12. Cytolytic Induction Therapy Improves Clinical Outcomes in African-American Kidney Transplant Recipients. Ann Surg. 2017 09; 266(3):450-456.
    View in: PubMed
    Score: 0.062
  13. Improvement in immunosuppression therapy monitoring in organ transplant recipients. Am J Health Syst Pharm. 2017 Sep 01; 74(17 Supplement 3):S67-S74.
    View in: PubMed
    Score: 0.062
  14. Morbid obesity and functional status as predictors of surgical complication after renal transplantation. Am J Surg. 2018 Apr; 215(4):663-668.
    View in: PubMed
    Score: 0.061
  15. Ambulatory Care Coordination Issues With Dual Use Veteran Organ Transplant Recipients. Prog Transplant. 2017 06; 27(2):187-191.
    View in: PubMed
    Score: 0.060
  16. Overall Graft Loss Versus Death-Censored Graft Loss: Unmasking the Magnitude of Racial Disparities in Outcomes Among US Kidney Transplant Recipients. Transplantation. 2017 Feb; 101(2):402-410.
    View in: PubMed
    Score: 0.059
  17. The Impact of Health Care Appointment Non-Adherence on Graft Outcomes in Kidney Transplantation. Am J Nephrol. 2017; 45(1):91-98.
    View in: PubMed
    Score: 0.058
  18. Outcome disparities between African Americans and Caucasians in contemporary kidney transplant recipients. Am J Surg. 2017 Apr; 213(4):666-672.
    View in: PubMed
    Score: 0.058
  19. Incidence and risk factors of hepatocellular carcinoma after orthotopic liver transplantation. Surgery. 2017 03; 161(3):830-836.
    View in: PubMed
    Score: 0.058
  20. Twenty years of evolving trends in racial disparities for adult kidney transplant recipients. Kidney Int. 2016 10; 90(4):878-87.
    View in: PubMed
    Score: 0.057
  21. Impact of Cardiovascular Risk Factors on Graft Outcome Disparities in Black Kidney Transplant Recipients. Hypertension. 2016 09; 68(3):715-25.
    View in: PubMed
    Score: 0.057
  22. Quantifying the Race Stratified Impact of Socioeconomics on Graft Outcomes in Kidney Transplant Recipients. Transplantation. 2016 07; 100(7):1550-7.
    View in: PubMed
    Score: 0.057
  23. Predicting and preventing readmissions in kidney transplant recipients. Clin Transplant. 2016 07; 30(7):779-86.
    View in: PubMed
    Score: 0.056
  24. Racial disparity outcomes in patients undergoing hepatectomy: is baseline kidney function a potential explanation? Prog Transplant. 2015 Sep; 25(3):257-62.
    View in: PubMed
    Score: 0.054
  25. Prediction of medication non-adherence and associated outcomes in pediatric kidney transplant recipients. Pediatr Transplant. 2015 Aug; 19(5):555-62.
    View in: PubMed
    Score: 0.052
  26. Hydroxyethyl starch and acute kidney injury in orthotopic liver transplantation: a single-center retrospective review. Anesth Analg. 2015 Mar; 120(3):619-626.
    View in: PubMed
    Score: 0.052
  27. Inclusion of dynamic clinical data improves the predictive performance of a 30-day readmission risk model in kidney transplantation. Transplantation. 2015 Feb; 99(2):324-30.
    View in: PubMed
    Score: 0.051
  28. Impact of Pharmacist Involvement in Early Identification and Enrollment in Patient Assistance Programs on CMV Outcomes in Transplantation. J Pharm Pract. 2016 Apr; 29(2):97-102.
    View in: PubMed
    Score: 0.050
  29. Cardiovascular risk factors contribute to disparities in graft outcomes in African American renal transplant recipients: a retrospective analysis. Blood Press. 2015 Feb; 24(1):14-22.
    View in: PubMed
    Score: 0.050
  30. Significant racial differences in the key factors associated with early graft loss in kidney transplant recipients. Am J Nephrol. 2014; 40(1):19-28.
    View in: PubMed
    Score: 0.049
  31. Lithium dosing equations: are they accurate? Ann Pharmacother. 2014 May; 48(5):596-600.
    View in: PubMed
    Score: 0.048
  32. Racial comparisons of everolimus pharmacokinetics and pharmacodynamics in adult kidney transplant recipients. Ther Drug Monit. 2013 Dec; 35(6):753-9.
    View in: PubMed
    Score: 0.047
  33. Are thiazide diuretics safe and effective antihypertensive therapy in kidney transplant recipients? Am J Nephrol. 2013; 38(4):285-91.
    View in: PubMed
    Score: 0.047
  34. Pre-existing diabetes significantly increases the risk of graft failure and mortality following renal transplantation. Clin Transplant. 2013 Mar-Apr; 27(2):274-82.
    View in: PubMed
    Score: 0.045
  35. Improving the perioperative value of care for vulnerable kidney transplant recipients. J Am Coll Surg. 2013 Apr; 216(4):668-76; discussion 676-8.
    View in: PubMed
    Score: 0.045
  36. The impact of cardiovascular disease and risk factor treatment on ethnic disparities in kidney transplant. J Cardiovasc Pharmacol Ther. 2013 May; 18(3):243-50.
    View in: PubMed
    Score: 0.044
  37. Medication errors and adverse drug events in kidney transplant recipients: incidence, risk factors, and clinical outcomes. Pharmacotherapy. 2012 Dec; 32(12):1053-60.
    View in: PubMed
    Score: 0.044
  38. No difference between smokers, former smokers, or nonsmokers in the operative outcomes of laparoscopic donor nephrectomies. Surg Laparosc Endosc Percutan Tech. 2009 Apr; 19(2):153-6.
    View in: PubMed
    Score: 0.034
  39. Long-term efficacy of induction therapy with anti-interleukin-2 receptor antibodies or thymoglobulin compared with no induction therapy in renal transplantation. Transplant Proc. 2008 Dec; 40(10):3401-7.
    View in: PubMed
    Score: 0.034
  40. Does bioequivalence between modified cyclosporine formulations translate into equal outcomes? Transplantation. 2005 Dec 15; 80(11):1633-5.
    View in: PubMed
    Score: 0.027
  41. Valganciclovir prophylaxis in patients at high risk for the development of cytomegalovirus disease. Transpl Infect Dis. 2004 Sep; 6(3):101-9.
    View in: PubMed
    Score: 0.025
  42. Evaluation of estimated and measured creatinine clearances for predicting the pharmacokinetics of vancomycin in adult liver transplant recipients. Ther Drug Monit. 2003 Feb; 25(1):67-72.
    View in: PubMed
    Score: 0.022
  43. Incidence and patterns of persistent opioid use in children following appendectomy. J Pediatr Surg. 2022 Dec; 57(12):912-919.
    View in: PubMed
    Score: 0.021
  44. Early Assessment of National Kidney Allocation Policy Change. J Am Coll Surg. 2022 04 01; 234(4):565-570.
    View in: PubMed
    Score: 0.021
  45. Surgical Outcomes Improvement and Health Inequity in a Regional Quality Collaborative. J Am Coll Surg. 2022 04 01; 234(4):607-614.
    View in: PubMed
    Score: 0.021
  46. Tacrolimus dosing requirements and concentrations in adult living donor liver transplant recipients. Liver Transpl. 2002 Mar; 8(3):219-23.
    View in: PubMed
    Score: 0.021
  47. The Magnitude and Potential Causes of Sex Disparities in Statin Therapy in Veterans with Type 2 Diabetes: A 10-year Nationwide Longitudinal Cohort Study. Womens Health Issues. 2022 May-Jun; 32(3):274-283.
    View in: PubMed
    Score: 0.021
  48. Unfractionated and Low-Molecular-Weight Heparin for Bridging Patients with Left Ventricular Assist Device: An Event-Based Analysis. ASAIO J. 2021 12 01; 67(12):1277-1283.
    View in: PubMed
    Score: 0.021
  49. The impact of race on metabolic, graft, and patient outcomes after pancreas transplantation. Am J Surg. 2022 04; 223(4):812-816.
    View in: PubMed
    Score: 0.020
  50. Impact of Anesthesiologist Experience on Early Outcomes in Adult Orthotopic Liver Transplantation. Transplant Proc. 2021 Jun; 53(5):1665-1669.
    View in: PubMed
    Score: 0.020
  51. Safety and Efficacy of Perioperative Sublingual Tacrolimus in Pancreas Transplant Compared With Oral Tacrolimus. Exp Clin Transplant. 2021 06; 19(6):592-595.
    View in: PubMed
    Score: 0.020
  52. Patterns of dispensed opioids after tonsillectomy in children and adolescents in South Carolina, United States, 2010-2017. Int J Pediatr Otorhinolaryngol. 2021 Apr; 143:110636.
    View in: PubMed
    Score: 0.019
  53. Facilitated Regional Collaboration and In-Hospital Surgical Complication. J Am Coll Surg. 2021 04; 232(4):536-543.
    View in: PubMed
    Score: 0.019
  54. Maintaining Equity and Access: Successful Implementation of a Virtual Kidney Transplantation Evaluation. J Am Coll Surg. 2021 04; 232(4):444-449.
    View in: PubMed
    Score: 0.019
  55. The impact of pretransplant opioid exposure on healthcare utilization and costs in kidney transplant. Pharmacotherapy. 2021 01; 41(1):6-13.
    View in: PubMed
    Score: 0.019
  56. Joint effect of race/ethnicity or location of residence and sex on low density lipoprotein-cholesterol among veterans with type 2 diabetes: a 10-year retrospective cohort study. BMC Cardiovasc Disord. 2020 10 15; 20(1):449.
    View in: PubMed
    Score: 0.019
  57. Impact of a multidisciplinary multimodal opioid minimization initiative in kidney transplant recipients. Clin Transplant. 2020 10; 34(10):e14006.
    View in: PubMed
    Score: 0.019
  58. An Evaluation of Statin Use Among Patients with Type 2 Diabetes at High Risk of Cardiovascular Events Across Multiple Health Care Systems. J Manag Care Spec Pharm. 2020 Sep; 26(9):1090-1098.
    View in: PubMed
    Score: 0.019
  59. Patterns of emergency department utilization between transplant and non-transplant centers and impact on clinical outcomes in kidney recipients. Clin Transplant. 2020 09; 34(9):e13983.
    View in: PubMed
    Score: 0.019
  60. Impact of Race and Location of Residence on Statin Treatment Among Veterans With Type 2 Diabetes Mellitus. Am J Cardiol. 2020 05 15; 125(10):1492-1499.
    View in: PubMed
    Score: 0.018
  61. Costs and factors associated with heart failure following kidney transplantation - a single-center retrospective cohort study. Transpl Int. 2020 04; 33(4):414-422.
    View in: PubMed
    Score: 0.018
  62. Protocol-based nurse coordinator management of ambulatory tacrolimus dosing in de novo renal transplant recipients-A single-center experience with a large African American population. Clin Transplant. 2019 10; 33(10):e13701.
    View in: PubMed
    Score: 0.018
  63. Long-standing diabetes mellitus and pancreas transplantation: An avenue to increase utilization of an ideal treatment modality. Clin Transplant. 2019 10; 33(10):e13695.
    View in: PubMed
    Score: 0.018
  64. Assessment of magnetic resonance imaging derived fat fraction as a sensitive and reliable predictor of myosteatosis in liver transplant recipients. HPB (Oxford). 2020 01; 22(1):102-108.
    View in: PubMed
    Score: 0.018
  65. Effect of Angiotensin II Inhibitors on Gastrointestinal Bleeding in Patients With Left?Ventricular Assist Devices. J Am Coll Cardiol. 2019 04 16; 73(14):1769-1778.
    View in: PubMed
    Score: 0.017
  66. Hospital admissions and emergency department visits among kidney transplant recipients. Clin Transplant. 2019 05; 33(5):e13522.
    View in: PubMed
    Score: 0.017
  67. Impact of Type 1 and Type 2 Diabetes Mellitus on Pancreas Transplant Outcomes. Exp Clin Transplant. 2019 12; 17(6):796-802.
    View in: PubMed
    Score: 0.017
  68. Investigating the Potential for Bias When Using a Widely Accepted Medication Adherence Measure to Predict Mortality. Pharmacotherapy. 2018 11; 38(11):1086-1094.
    View in: PubMed
    Score: 0.017
  69. Association of Pretransplantion Opioid Use with Graft Loss or Death in Liver Transplantation Patients with Model of End-Stage Liver Disease Exceptions. J Am Coll Surg. 2018 04; 226(4):651-659.
    View in: PubMed
    Score: 0.016
  70. Big Data, Predictive Analytics, and Quality Improvement in Kidney Transplantation: A Proof of Concept. Am J Transplant. 2017 03; 17(3):671-681.
    View in: PubMed
    Score: 0.015
  71. Utility of the Surgical Apgar Score in Kidney Transplantation: Is it Feasible to Predict ICU Admission, Hospital Readmission, Length of Stay, and Cost in This Patient Population? Prog Transplant. 2016 Jun; 26(2):122-8.
    View in: PubMed
    Score: 0.014
  72. Does African American Race Impact Statin Efficacy in Renal Transplant Outcomes? Medicine (Baltimore). 2015 Dec; 94(49):e2283.
    View in: PubMed
    Score: 0.014
  73. Incidence, risk factors, and outcomes of opportunistic infections in pediatric renal transplant recipients. Pediatr Transplant. 2016 Feb; 20(1):44-8.
    View in: PubMed
    Score: 0.014
  74. Optimizing finite resources: Pharmacist chart reviews in an outpatient kidney transplant clinic. J Am Pharm Assoc (2003). 2015 Nov-Dec; 55(6):613-620.
    View in: PubMed
    Score: 0.014
  75. Is cirrhosis a contraindication to laparoscopic cholecystectomy? Am Surg. 2015 Jan; 81(1):52-5.
    View in: PubMed
    Score: 0.013
  76. Clinical outcomes and costs associated with in-hospital biliary complications after liver transplantation: a cross-sectional analysis. J Gastrointest Surg. 2015 Feb; 19(2):282-9.
    View in: PubMed
    Score: 0.013
  77. The impact of diabetes mellitus and glycemic control on clinical outcomes following liver transplant for hepatitis C. Clin Transplant. 2014 Aug; 28(8):862-8.
    View in: PubMed
    Score: 0.012
  78. Clinical outcomes associated with the early postoperative use of heparin in pancreas transplantation. Transplantation. 2014 Mar 27; 97(6):681-5.
    View in: PubMed
    Score: 0.012
  79. Timing of factor VIIa in liver transplantation impacts cost and clinical outcomes. Pharmacotherapy. 2013 May; 33(5):483-8.
    View in: PubMed
    Score: 0.011
  80. Improving transplant patient safety through pharmacist discharge medication reconciliation. Am J Transplant. 2013 Mar; 13(3):796-801.
    View in: PubMed
    Score: 0.011
  81. Safety and effectiveness outcomes of an inpatient collaborative drug therapy management service for direct thrombin inhibitors. Am J Health Syst Pharm. 2012 Nov 15; 69(22):1993-8.
    View in: PubMed
    Score: 0.011
  82. The impact of early corticosteroid withdrawal on graft survival in liver transplant recipients. Transplant Proc. 2012 Jun; 44(5):1323-8.
    View in: PubMed
    Score: 0.011
  83. Leflunomide efficacy and pharmacodynamics for the treatment of BK viral infection. Clin J Am Soc Nephrol. 2012 Jun; 7(6):1003-9.
    View in: PubMed
    Score: 0.011
  84. Potential differences in kidney allograft outcomes between ethnicities when converting to sirolimus base immunosuppression. Transplant Proc. 2009 Dec; 41(10):4131-7.
    View in: PubMed
    Score: 0.009
  85. Comparison of efficacy of induction therapy in low immunologic risk African-American kidney transplant recipients. Transpl Int. 2010 May 01; 23(5):500-5.
    View in: PubMed
    Score: 0.009
  86. Efficacy of induction therapy on acute rejection and graft outcomes in African American kidney transplantation. Clin Transplant. 2010 Jan-Feb; 24(1):40-7.
    View in: PubMed
    Score: 0.009
  87. Long-term outcome of sirolimus rescue in kidney-pancreas transplantation. Transplantation. 2004 Aug 27; 78(4):619-22.
    View in: PubMed
    Score: 0.006
  88. Does treatment of cadaveric organ donors with desmopressin increase the likelihood of pancreas graft thrombosis? Results of a preliminary study. Transplant Proc. 2004 May; 36(4):1048-9.
    View in: PubMed
    Score: 0.006
  89. Long-term outcome of sirolimus rescue in kidney-pancreas transplantation. Transplant Proc. 2004 May; 36(4):1058-60.
    View in: PubMed
    Score: 0.006
  90. Influence of mild obesity on outcome of simultaneous pancreas and kidney transplantation. J Gastrointest Surg. 2003 Dec; 7(8):1096-101.
    View in: PubMed
    Score: 0.006
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.